Kimberly Lewandowski-Walker

FDA investigator

Appears on 5 documents from 2005 to 2017, most often at sites in Florida. Most often cites corrective and preventive action (21 CFR 820.100).

5
Documents on file
8.8
Observations per 483
2005
First seen
2017
Most recent

What they cite most

From 27 observations

Activity by year

2005: 1, 2010: 1, 2015: 2, 2017: 1

Where

Florida 1 · Indiana 1 · Minnesota 1 · Puerto Rico 1 · Texas 1

Is Kimberly Lewandowski-Walker coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Oscor, IncMar 23, 2017 · Palm Harbor, Florida
483 Zimmer Manufacturing B.VNov 17, 2015 · Mercedita, Puerto Rico
Amended 483 Terumo Cardiovascular Systems CorporationJul 11, 2015 · Ann Arbor, Indiana
Response Advanced Neuromodulation Systems, Inc.Sep 15, 2010 · Plano, Texas
483 Guidant CorporationSep 1, 2005 · Saint Paul, Minnesota

About this profile

What does Kimberly Lewandowski-Walker inspect?

Kimberly Lewandowski-Walker appears on 5 documents on file covering 4 sites, most often in Florida.

What do they cite most often?

21 CFR 820.100 (corrective and preventive action), followed by 21 CFR 820.75 and 21 CFR 820.184.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kimberly Lewandowski-Walker is dated Mar 23, 2017.